CClinicalTrials.gg
CompletedNCT03945669IMVEXUpdated Jun 25, 2024

Intramedullary Nailing vs External Ring Fixation for the Treatment of Tibial Shaft Fractures

An interventional study of Intramedullary Nailing and External Ring fixation in Tibial Shaft Fracture, sponsored by Aalborg University Hospital. Completed at 3 sites in Denmark. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-06-25.

Sponsored by Aalborg University Hospital · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
67
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study is a multicenter pragmatic assessor blinded randomized and prospective clinical trial in which standard intramedullary nailing is compared with external ring fixator for patients with tibial shaft fractures.

Read the detailed description

This study is a multicenter pragmatic assessor blinded randomized and prospective clinical trial in which standard intramedullary nailing is compared with external ring fixator for patients with tibial shaft fractures.

The primary aim of the project is to compare the one-year Knee Injury and Osteoarthritis Outcome Score - Sport (KOOS-Sport) after standard intramedullary nailing with external ring fixation for patients with tibial shaft fractures.

The explorative aim is to report the effect of the two surgical procedures on the development of complications, time to bone union, pain reactions, muscle strength, activity of daily living and time to return to work.

02

Conditions studied

  • Tibial Shaft Fracture

Browse trials for

Keywords

  • External ring fixation
  • Intramedullary nailing
  • Tibial shaft fracture
  • patient reported outcome
03

In context

Fractures, Bone

2,261 studies on the registry are indexed under Fractures, Bone; 325 are open to participants now.

This study's enrollment of 67 is close to the median of 69 across 1,482 interventional studies indexed under Fractures, Bone.

Browse Fractures, Bone studies →

Lead sponsor

Aalborg University Hospital is the lead sponsor of 195 studies on the registry; 39 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Fracture of the tibial shaft
  • OTA classification Type: 42-A1-A3, -B1-B3 and -C1-C3
  • The fracture type is deemed operable by intramedullary nail

Exclusion criteria

Exclusion Criteria:

  • Below 18 years of age
  • Open fracture
  • History of severe systemic diseases or cancer
  • Bilateral tibial shaft fracture
  • Multi fracture patients
  • Pregnancy
  • Patients without gait function prior to fracture
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
67 participants (actual)

Study arms

  • Active comparator
    Intramedullary Nail

    Intramedullary Nailing: Alignment will be obtained by closed or limited open reduction of the fracture. A standard reamed intramedullary nail is inserted. Access above the patella, through the patella tendon or parapatellar access is used according to surgeon preferences. One or more cortical screws may be used if deemed appropriate due to fracture pattern. Patients are administered preoperative antibiotics (Dicloxacillin) 15 minutes before surgery commences. Postoperative antibiotics is administered by discretion of the surgeon based on individual patient considerations.

    Procedure: Intramedullary Nailing

  • Experimental
    External Ring fixator

    External Ring fixation: Closed or limited open reduction of the fracture is performed. A circular frame is attached on both sides of the fracture. Connection to the bone is obtained by hydroxyapatite coated half pins and/or k-wires with olives as needed according to surgeon preferences. One or more cortical screws may be used if deemed appropriate due to fracture pattern. After applying the ring fixator alignment is assessed radiologically and corrected both peri- and postoperatively. Patients are administered preoperative antibiotics (Dicloxacillin) preoperatively 15 minutes before surgery commences. Following surgery antibiotics are continued until wounds, pin- and wire perforations are dry.

    Procedure: External Ring fixation

Interventions

  • ProcedureIntramedullary Nailing

    fracture fixation of the tibial shaft fracture with an intramedullary nail.

  • ProcedureExternal Ring fixation

    fracture fixation of the tibial shaft fracture with an external ring fixator.

06

What researchers measure

Primary outcomes

  1. The Knee Injury and Osteoarthritis Outcome Score - sport (KOOS Sport)

    KOOS-sport is a standardized and validated patient-reported instrument used in order to assess knee and knee associated problems with regards to activity. The subscale sport is one five subscales: pain, ADL, symptoms, sport and QOL in the KOOS questionnaire . A total score of 100 indicates no symptoms, and 0 indicates major symptoms.

    Time frame: 12 month follow up

Secondary outcomes

  1. Perceived Pain

    Development in pain in the two groups will be recorded by patient-reported pain intensity measured on a 10 cm visual analogue scale (VAS) with endpoints "no pain" and "maximal pain" for the worst pain during the last 24 hours and resting pain.

    Time frame: 6 weeks, 3+6+12 months

  2. Patient-reported pain reactions

    Pain DETECT questionnaire. The painDETECT screening questionnaire (PD-Q), uses a scoring method between - 1 and 38 to estimate the likelihood of a neuropathic pain component in patients.

    Time frame: 6 weeks, 3+6+12 months

  3. Pain sensitivity

    Pain sensitivity will be assessed by pressure pain thresholds (PPTs) recorded by handheld pressure algometry (Algometer Type II, Somedic AB, Sweden).

    Time frame: 6 weeks, 3+6+12 months

  4. Muscle strength

    Isometric muscle strength in the two groups will be measured by a strap-mounted dynamometer attached to the wall (Mecmesin AFG2500, Mecmesin Ltd, West Sussex, UK). Girth measures of thigh and calf will be used to examine muscle atrophy and/or effusion

    Time frame: 6+12 months

  5. Time to bone union

    Bone union, in the two surgical groups will be evaluated on standard AP and side X-rays of the fractured leg. The evaluation of bone union will be defined as: i) visible callus formation on at least three of four sides, no visible fracture line and no pain from fracture site at weight-bearing and during clinical examination.

    Time frame: 6 weeks, 3+6+12 months

  6. Radiological alignment

    Alignment of the tibia will be evaluated using the EOS scanning system.

    Time frame: 6 weeks, 3+6+12 months

  7. Health related QOL

    Eq5D-5L is a standardized questionnaire developed to assess general health outcome (29). It consists of five dimensions: Mobility, self-care, usual activities, pain/discomfort and anxiety/depression, and a self-rated health scale on a 20 cm vertical, visual analogue scale with endpoints labelled 'the best health you can imagine' and 'the worst health you can imagine'. An Eq5d-5L index of 1.0 indicated full health, 0 death, and -0.59 denoted a condition worse than death

    Time frame: 6 weeks, 3+6+12 months

  8. Time to return to work

    Measure the time from surgery to end of sick leave measured in days.

    Time frame: 6 weeks, 3+6+12 months

  9. Health economic evaluation

    Measure the cost of treatment in the two groups within the first year following surgery

    Time frame: 12 months

  10. Gait assessment

    Gait asymmetries will be measured with patients walking on a pressure-sensitive mat.

    Time frame: 3+6+12 months

  11. Patient Acceptable Symptom State (PASS)

    This instrument evaluate when the patient reaches a acceptable patient observed pain and function level, where the patient no longer demands treatment

    Time frame: 3+6+12 months

  12. The Knee Injury and Osteoarthritis Outcome Score (KOOS)

    KOOS is a standardized and validated patient-reported instrument used in order to assess knee and knee associated problems.The questionnaire includes five subscales: pain, ADL, symptoms, sport and QOL. A total score of 100 indicates no symptoms, and 0 indicates major symptoms.

    Time frame: 6 weeks, 3+6+12 months

  13. Foot And Ankle Outcome Score (FAOS)

    FAOS is a standardized and validated patient-reported instrument used in order to assess foot and ankle associated problems divided into 5 subscales. The questionnaire includes five subscales: pain, ADL, symptoms, sport and QOL. A total score of 100 indicates no symptoms, and 0 indicates major symptoms.

    Time frame: 6 weeks, 3+6+12 months

Other outcomes

  1. Adverse events

    Adverse events, defined as any negative or unwanted reactions to the two surgical procedures, will be recorded. These will include deep infection, pin infection, skin infections, malalignment, compartment syndrome or any other reported physical discomfort. An adverse effects committee will manage adverse reactions at the time of the adverse reaction.

    Time frame: 6 weeks, 3+6+12 months

07

Study locations

3 sites
  • Aalborg University Hospital, Department of orthopaedic surgery
    Aalborg, 9000, Denmark
  • Aarhus University Hospital
    Aarhus, 8000, Denmark
  • Regional Hospital Viborg
    Viborg, 8800, Denmark
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 25, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03945669
Lead sponsor
Aalborg University Hospital
Collaborators
Danish Council for Independent Research
Responsible party
Rasmus Elsøe (Head of Orthopaedic trauma, Aalborg University Hospital) — Principal investigator
First posted
May 10, 2019
Start date
Nov 1, 2019
Primary completion
Jun 24, 2024
Completion
Jun 24, 2024
Last update
Jun 25, 2024

Study contacts

Rasmus Elsøe, PhD
study director · Aalborg University Hospital
Rasmus Stokholm, MD
principal investigator · Aalborg University Hospital
Peter Larsen, PhD
principal investigator · Aalborg University Hospital

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion